Gonadotrophin-releasing hormone antagonists for assisted reproductive technology in women with poor ovarian response. Subgroup analysis of Cochrane systematic.

Slides:



Advertisements
Similar presentations
ALTERNATE DAY TRIPTORELIN: A COST EFFECTIVE METHOD FOR CONTROLLED OVARIAN HYPERSTIMULATION E. Karatekeli, H. Özörnek, E. Ergin, B. Ongun EUROFERTIL REPRODUCTIVE.
Advertisements

What is a systematic review a review strives to comprehensively identify and track down all the literature on a given topic incorporates a specific.
In the name of GOD In the name of GOD.
Occupational Therapy for patients with problems in personal activities of daily living after stroke. Avril Drummond April, 2008.
A systematic review of the analgesic efficacy and adverse effects of epidural morphine versus parenteral morphine after caesarean section Carmen KM Chan.
Elonva in poor responders
QUASI-EXPERIMENTAL STUDY DESIGNS IN EVALUATING MEDICINES USE INTERVENTIONS 1 Lloyd Matowe 2 Craig Ramsay 1 Faculty of Pharmacy, Kuwait University 2 HSRU,
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.
INDIVIDUALIZED IVF TREATMENT
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation
E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
The uses of antagonist in IVF/ICSI cycle Prof. Dr. Mohamed Said Elmahaishi Lamis IVF Centre Misurata/ Libya 5 th International Congress In Infertility.
Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles? Peter Platteau, Johan Smitz, Carola Albano, Per Sørensen Joan-Carles Arce.
Developing Research Proposal Systematic Review Mohammed TA, Omar Ph.D. PT Rehabilitation Health Science.
LUTEAL PHASE SUPPORT An evidence-based approach M. Aboulghar Cairo – Egypt IZMIR 2008.
ART Assisted reproductive technology Dithawut Khrutmuang MD.
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Planning of GnRH antagonist cycles
Levent M. SENTURK, M.D., Professor in Ob&Gyn Istanbul University Cerrahpasa School of Medicine Dept. of Ob&Gyn, Division of Reproductive Endocrinology,
Dr. Milton Leong Director
Systematic Reviews.
The Effect of Bromocriptine-Rebound Method on Ongoing Pregnancy and Live Birth after Intracytoplasmic Sperm Injection Cycles: a Randomized Clinical Trial.
Evidence Based Medicine Meta-analysis and systematic reviews Ross Lawrenson.
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
SL ‘00 Antagonists in patients with previous poor ovarian response Antagonists in patients with previous poor ovarian response Geoffrey H Trew Consultant.
Agonist vs Antagonist Dr. Milton Leong.
How to schedule GnRH antagonist cycles?
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
A review on the luteal phase P Devroey MD PhD Centre for Reproductive Medicine Dutch-speaking Brussels Free University Brussels - Belgium.
2nd Concertation Meeting Brussels, September 8, 2011 Reinhard Prior, Scientific Coordinator, HIM Evidence in telemedicine: a literature review.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
Review Characteristics This review protocol was prospectively registered with BEME (see flow diagram). Total number of participants involved in the included.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
1 Lecture 10: Meta-analysis of intervention studies Introduction to meta-analysis Selection of studies Abstraction of information Quality scores Methods.
/ 42 1 Acupuncture or acupressure for pain management in labour. (review of systematic reviews)
UOG Journal Club: August 2016 Dydrogesterone versus progesterone for luteal- phase support: systematic review and meta-analysis of randomized controlled.
A Summary of a Systematic Review Robert Williams, LCSW, BCD University of Utah.
UOG Journal Club: August 2016
Surgery versus conservative management of endometriomas in subfertile women. A systematic review JACOB BRINK LAURSEN1, JEPPE B. SCHROLL2, KIRSTEN T. MACKLON3.
UOG Journal Club: February 2016
Effectiveness of yoga for hypertension: Systematic review and meta-analysis Marshall Hagins, PT, PhD1, Rebecca States,
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
How IVF Protocols Work to Enhance the Success of IVF: Agonist vs Antagonist Dr Dimitrios Dovas MD Newlife IVF Greece.
25 – 26 March 2013 University of Oxford Intubation or CPAP ?
Drug protocols for ovulation induction. A
Drug protocols for ovulation induction. A
Ovarian Hyper Stimulation Syndrome (OHSS)
Institute of Health and Society, Newcastle University
UOG Journal Club: October 2016
Isfahan University of Medical Sciences Dissertation defense meeting Resident of Gynecology and Obstetrics.
Use of GnRH antagonists for IVF
Mohamed Elmahdy MD. Lecturer Obs. Gyn. Alexandria University Egypt
The approach to the PCOS patient undergoing IVF
Özkan Özdamar, M.D., Assist. Prof.
Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:
M.Vooijs, P.Siemonsma, I.Heus, J.Sont, A.Rövekamp, N. van Meeteren
UOG Journal Club: January 2018
Drug protocols for ovulation induction. A
The effect of the duration of stimulation on ART outcomes
Antagonists in poor-responder patients
UOG Journal Club: December 2016
Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome.
Geir Smedslund, Ph.D.: Diakonhjemmet Hospital (DH)
Ovarian stimulation protocols for IVF: is more better than less?
Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf 
How to do a study? Prof. P. Devroey.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Does cinnamon reduce fasting blood glucose in Type II diabetics?
Presentation transcript:

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology in women with poor ovarian response. Subgroup analysis of Cochrane systematic review and meta- analysis Youssef MAFM, Hesham G Al-Inany, Mohamed Aboulghar, Frank Broekmans, Monique Sterrenburg, Janine Smit, Ahmed M Abou-Setta Cairo University

? What is the problem ? ≈ 9-24% of IVF/ICSI patients respond poorly to ovarian stimulation !!! Poor ovarian responders

Natural Populations

ART Populations

Is there a treatment for poor ovarian responders ?

Different treatment options 1. 1.Various Pituitary down regulation protocols& 2.High dose or mild dose of Gn.

Pituitary downregulation protocols Short GnRH agonist 2. 2.Long GnRH agonist 3. 3.GnRH antagonist 4. 4.Natural cycle

Long GnRH agonist Long GnRH agonist is the standard protocol used for poor responders, however, this protocol has many drawbacks: 1.Prolonged duration of ovarian stimulation, 2.Multiple injections, 3.More patient’s distress 4.Increased the cost without improving IVF outcome kasr al ainy school of Medicine Cairo University

GnRH antagonist protocol Last decade, GnRH antagonist has been emerged as an alternative to GnRH agonist protocols in IVF/ICSI cycles. GnRH antagonists competitively desensitize pituitary GnRH receptors immediate & reversible suppression of gonadotropin secretion kasr al ainy school of Medicine Cairo University

GnRH antagonist protocol Due to these pharmacokinetic characteristics it was anticipated that, GnRH antagonists are an optimal alternative to long GnRH agonist because their use occurs after the commencement of gonadotropin stimulation, thus theoretically:- 1.Minimizing their impact on early follicular recruitment 2.Reduces suppression of endogenous gonadotrophins. kasr al ainy school of Medicine Cairo University

GnRH antagonist protocol GnRH antagonist might have many advantages over GnRH agonist such as:- 1.Fewer injections, 2.Shorter duration of stimulation, 3.Less incidence of OHSS. kasr al ainy school of Medicine Cairo University

GnRH antagonist protocol So it has been promised to be more patient friendly than long GnRH agonist in general, however, there is a great controversy about its impact on pregnancy outcomes in poor responders kasr al ainy school of Medicine Cairo University

Aim of the review The aim of this subgroup analysis of the recently published Cochrane review was to compare GnRH antagonist desensitization protocol with the standard long GnRH agonist in women with poor ovarian response undergoing IVF/ICSI treatment cycles kasr al ainy school of Medicine Cairo University

Inclusion criteria Type of studies: RCT Participants: Infertile couples with poor ovarian response undergoing IVF/ICSI Intervention: Long GnRH agonist protocol versus GnRH antagonist protocol for pituitary downregulation kasr al ainy school of Medicine Cairo University

Outcomes Primary outcome: Ongoing pregnancy rate Secondary outcomes: 1.Clinical pregnancy rate 2.Duration of ovarian stimulation & amount of Gonadotropin used, 3.Number of retrieved oocytes 4.Cycle cancellation rate kasr al ainy school of Medicine Cairo University

Literature search Menstrual Disorders & Subfertility Group's Specialised Register of controlled trials The Cochrane Central Register of Controlled Trials (CENTRAL) MEDLINE (1966 to Jan 2011) EMBASE (1980 to Jan 2011) National Research Register Web-based trials databases such as Current Controlled Trials References check. We also contacted drug companies for any published, unpublished or ongoing studies not identified with our search strategy No language restriction kasr al ainy school of Medicine Cairo University

Results

Flow diagram of study selection kasr al ainy school of Medicine Cairo University Publications excluded, (n= 19) RCTs included in meta-analysis (n=6) RCTs withdrawn (n=0) RCTs with usable information (n=6) 1.Inza Cheung Marci Tazegul Kim Sbarcia 2009 Potentially relevant publications identified and screened for retrieval (n= 25)

Ongoing pregnancy rate

Clinical pregnancy rate

No. retrieved oocytes

Cancellation rate

Duration of stimulation

Amount of Gonadotropins

Studies characteristics The overall methodological quality of the trials was: Good 2. 2.Published as a full manuscript in peer-reviewed journals The studies were generally small and not well powered for all the clinical relevant outcomes In five of six randomized trials, concealment of allocation was not clearly described 5. 5.In three studies there was no blinding and in two studies it was unclearly reported 6. 6.An intention to treat analysis was stated to have been carried out in only one study

Results Consistencies were found among the studies in outcomes such as OPR, CPR & cancellation rate There were Inconsistencies between studies in outcomes such as number of oocytes, duration of stimulation and amount of Gn used.

Summary of results The present meta-analysis indeed suggests that GnRH antagonist in poor responders result in: ≈ Comparable pregnancy rates ≈ Comparable number of retrieved follicles ≈ Comparable cancellation rate 4. 4.Shorter duration of stimulation 5. 5.Less amount of Gn kasr al ainy school of Medicine Cairo University

Take home message In view of its equivalence, GnRH antagonist is an alternative for long GnRH agonist in poor responder patients undergoing ovarian stimulation and IVF/ICSI cycles kasr al ainy school of Medicine Cairo University

Results Although the inconsistency of studies ‘results in a meta-analysis reduces the confidence of recommendations about treatment, it is an expected due to clinical and methodological diversity between studies such as inclusion criteria for participation and study quality but it cannot be regarded as a major cause of the differences in the results of the studies included in this subgroup analysis